Antimicrobial Treatment and Prophylaxis of Plague: Recommendations for Naturally Acquired Infections and Bioterrorism Response

The goal of this activity is to describe Centers for Disease Control and Prevention recommendations to US healthcare providers regarding treatment, pre-exposure prophylaxis, and postexposure prophylaxis of plague, both for naturally acquired infections and for bioterrorism response.

Target Audience

This activity is intended for infectious disease clinicians, bioterrorism experts, public health officials, internists, pediatricians, intensivists, and other clinicians caring for patients with or at risk for plague.

Learning Objectives

Upon completion of this activity, participants will:

  1. Describe notable changes and updates in the new Centers for Disease Control and Prevention (CDC) recommendations compared with the Working Group on Civilian Biodefense guidelines published in 2000, based on new data, expert forum discussions, and other developments
  2. Determine additional considerations regarding response to Yersinia pestis release as a biological weapon, according to the new CDC recommendations
  3. Identify additional recommendations regarding treatment, pre-exposure prophylaxis, and postexposure prophylaxis of adults and children, according to the new CDC guidelines

Additional Information

Partner: 
Medscape
State Relevance: 
Nevada
Course summary
Available credit: 
  • 2.00 ABMS MOC
  • 2.00 AMA PRA Category 1 Credit
  • 2.00 ANCC
Course opens: 
09/14/2021
Course expires: 
09/14/2022
Rating: 
0

Christina A. Nelson, MD, MPH
Bacterial Diseases Branch
Division of Vector-Borne Diseases
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention (CDC)
Fort Collins, Colorado
Disclosure: Christina A. Nelson, MD, MPH, has disclosed no relevant financial relationships.

Dana Meaney-Delman, MD, MPH
Infant Outcomes Monitoring, Research and Prevention Branch
Division of Birth Defects and Infant Disorders
National Center on Birth Defects and Developmental Disabilities
Centers for Disease Control and Prevention (CDC)
Atlanta, Georgia
Disclosure: Dana Meaney-Delman, MD, MPH, has disclosed no relevant financial relationships.

Shannon Fleck-Derderian, MPH
Bacterial Diseases Branch
Division of Vector-Borne Diseases
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention (CDC)
Fort Collins, Colorado
Disclosure: Shannon Fleck-Derderian, MPH, has disclosed no relevant financial relationships.

Katharine M. Cooley, MPH
Bacterial Diseases Branch
Division of Vector-Borne Diseases
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention (CDC)
Fort Collins, Colorado
Disclosure: Katharine M. Cooley, MPH, has disclosed no relevant financial relationships.

Patricia A. Yu, MPH
Emergency Preparedness and Response Branch
Division of Preparedness and Emerging Infections
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention (CDC)
Atlanta, Georgia
Disclosure: Patricia A. Yu, MPH, has disclosed no relevant financial relationships.

Paul S. Mead, MD, MPH
Bacterial Diseases Branch
Division of Vector-Borne Diseases
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention (CDC)
Fort Collins, Colorado
Disclosure: Paul S. Mead, MD, MPH, has disclosed no relevant financial relationships.

CME Author

Laurie Barclay, MD
Freelance writer and reviewer
Medscape, LLC
Disclosure: Laurie Barclay, MD, has disclosed no relevant financial relationships.

CME Reviewer/Nurse Planner

Stephanie Corder, ND, RN, CHCP
Associate Director, Accreditation and Compliance
Medscape, LLC
Disclosure: Stephanie Corder, ND, RN, CHCP, has disclosed no relevant financial relationships.

Medscape, LLC staff have disclosed that they have no relevant financial relationships.

Disclosures

As an organization accredited by the ACCME, Medscape, LLC requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.

 

 

In support of improving patient care, Medscape LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

  • For Physicians
    Medscape, LLC designates this enduring material for a maximum of 2.00 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.00 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • For Nurses
    Awarded 2.00 contact hour(s) of nursing continuing professional development for RNs and APNs; 0 contact hours are in the area of pharmacology.

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

Available Credit

  • 2.00 ABMS MOC
  • 2.00 AMA PRA Category 1 Credit
  • 2.00 ANCC
Please login or register to take this course.

This course is offered through Medscape. 

To take this course you will be redirected to Medscape's website. You must login or create an account with Medscape in order to complete this activity. 

Mocingbird works to provide curated, high quality content to our users. Have a suggestion? Want to partner with us? Get in touch!

Topics

BioterrorismCDC Guidelines